Baidu
map

2016 WFSBP专家共识:精神科患者激越的评估和管理

2016-03-01 世界生物精神病学会联合会 World J Biol Psychiatry. 2016 Mar;17(2):86-128.

2016年3月,世界生物精神病学会联合会(WFSBP)发布了精神科患者激越的评估和管理专家共识,该专家共识从病因及差异诊断评估,非药物干预,药物干预和特殊亚群四个方面提出了22条专家共识意见。

中文标题:

2016 WFSBP专家共识:精神科患者激越的评估和管理

英文标题:

Assessment and management of agitation in psychiatry: Expert consensus.

发布日期:

2016-03-01

简要介绍:

2016年3月,世界生物精神病学会联合会(WFSBP)发布了精神科患者激越的评估和管理专家共识,该专家共识从病因及差异诊断评估,非药物干预,药物干预和特殊亚群四个方面提出了22条专家共识意见。


拓展指南:精神病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 WFSBP专家共识:精神科患者激越的评估和管理)] GetToolGuiderByIdResponse(projectId=1, id=115c31c001a4219d, title=2016 WFSBP专家共识:精神科患者激越的评估和管理, enTitle=Assessment and management of agitation in psychiatry: Expert consensus., guiderFrom=World J Biol Psychiatry. 2016 Mar;17(2):86-128., authorId=null, author=, summary=2016年3月,世界生物精神病学会联合会(WFSBP)发布了精神科患者激越的评估和管理专家共识,该专家共识从病因及差异诊断评估,非药物干预,药物干预和特殊亚群四个方面提出了22条专家共识意见。, cover=, journalId=null, articlesId=null, associationId=324, associationName=世界生物精神病学会联合会, associationIntro=Founded in 1974 in Buenos Aires, Argentina, the World Federation of Societies of Biological Psychiatry is a non-profit, international organization composed of over 60 national societies of biological psychiatry, representing over 4,500 professionals. As a world authority on biological psychiatry, WFSBP is also highly committed to pioneering and promoting the highest levels of education and dissemination within the field., copyright=0, guiderPublishedTime=Tue Mar 01 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年3月,世界生物精神病学会联合会(WFSBP)发布了精神科患者激越的评估和管理专家共识,该专家共识从病因及差异诊断评估,非药物干预,药物干预和特殊亚群四个方面提出了22条专家共识意见。 <div><br> </div> 拓展指南:<strong>与<font color="red">精神病</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=e76fb1c001a06285" title="2015 RANZCP指南:精神病学实践中应用苯二氮䓬类药物指导" target="_blank">2015 RANZCP指南:精神病学实践中应用苯二氮䓬类药物指导</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=62eca1c00139999d" title="抗精神病药所致高催乳素血症:多学科专家共识" target="_blank">抗精神病药所致高催乳素血症:多学科专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=d96a31c0013e806c" title="2017 多学科共识建议:继发于抗精神病药物的医源性高催乳素血症的治疗" target="_blank">2017 多学科共识建议:继发于抗精神病药物的医源性高催乳素血症的治疗</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=674c81c00131e0c5" title="2016 应用长效可注射性抗精神病药物治疗精神分裂症:证据评估" target="_blank">2016 应用长效可注射性抗精神病药物治疗精神分裂症:证据评估</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=530c01c001293144" title="2016 BAP指南:精神病和抗精神病药物治疗相关性体重增加,代谢紊乱和心血管风险的管理" target="_blank">2016 BAP指南:精神病和抗精神病药物治疗相关性体重增加,代谢紊乱和心血管风险的管理</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E7%B2%BE%E7%A5%9E%E7%97%85" target="_blank">有关精神病更多指南</a></ul>, tagList=[TagDto(tagId=116, tagName=精神科), TagDto(tagId=4501, tagName=患者), TagDto(tagId=46094, tagName=激越), TagDto(tagId=8315, tagName=评估), TagDto(tagId=4059, tagName=管理)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3929, appHits=150, showAppHits=0, pcHits=2629, showPcHits=1826, likes=108, shares=16, comments=2, approvalStatus=1, publishedTime=Thu May 25 12:21:36 CST 2017, publishedTimeString=2016-03-01, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Thu May 25 12:21:36 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:32:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 WFSBP专家共识:精神科患者激越的评估和管理)])
2016 WFSBP专家共识:精神科患者激越的评估和管理
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=914801, encodeId=7be5914801c9, content=要学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/01/23/1c44acf24dce138a19f076ec9f6b4ae4.jpg, createdBy=6dfa2495103, createdName=Carl1146, createdTime=Sat Jan 09 08:46:25 CST 2021, time=2021-01-09, status=1, ipAttribution=)]
    2021-01-09 Carl1146

    要学习一下

    0

Baidu
map
Baidu
map
Baidu
map